Viteva  Home logo
Supplement Safety

 Untitled 1
Lycopene Research

Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study.

Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.

Lycopene and prostate cancer.

Effect of lycopene supplementation on lung function after exercise in young athletes who complain of exercise-induced bronchoconstriction symptoms.

Effect of lycopene supplementation on insulin-like growth factor-1 and insulin-like growth factor binding protein-3: a double-blind, placebo-controlled trial.

A tomato-based, lycopene-containing intervention for androgen-independent prostate cancer: results of a Phase II study from the North Central Cancer Treatment Group.

Tomato lycopene extract supplementation decreases insulin-like growth factor-I levels in colon cancer patients.

The opposite associations of lycopene and body fat mass with humoral immunity in type 2 diabetes mellitus: a possible role in atherogenesis.

Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer.

Lycopene inhibits disease progression in patients with benign prostate hyperplasia.

Lycopene-rich treatments modify noneosinophilic airway inflammation in asthma: proof of concept.

Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer risk.

A dose-response study on the effects of purified lycopene supplementation on biomarkers of oxidative stress.

Protective effect of lycopene in cardiovascular disease.
 Untitled 1
   Home    Terms of Use    Privacy
Home    Research    Terms of Use    Privacy Policy    Advertise    Newsletter    About Us    Contact Us
Copyright ©2009 Viteva